highperformr logo

Celmatix Therapeutics's Overview

Total employees24
HeadquartersNew York
Founded2009

Celmatix was a next-generation women’s health company dedicated to transforming reproductive healthcare through data-driven, personalized medicine. By leveraging big data, genomics, and artificial intelligence, Celmatix developed innovative products aimed at improving fertility outcomes and overall women's health. Key contributions included the Fertilome® genetic test and a proprietary data platform designed to provide deeper insights into female reproductive biology. In June 2022, Celmatix's key assets, including its preclinical-stage MAGE-A9 program, Fertilome® test, and digital platform, were acquired by Organon, a global women's health company, to further accelerate innovation in the field.

Where is Celmatix Therapeutics's Headquarters?

HQ Function

The New York headquarters served as the core for Celmatix's operations, including research and development, data science, product innovation, and corporate strategy, driving its mission in advancing women's reproductive health.

Notable Features:

Celmatix's office was situated in a modern commercial building in Manhattan's Financial District, offering a dynamic environment and access to collaborative workspaces. Specific internal architectural details were proprietary to their leased space.

Work Culture:

Celmatix cultivated a mission-driven, innovative, and collaborative work environment. The team was characterized by a passion for applying cutting-edge science and technology to solve complex challenges in women's health, emphasizing data-informed decisions and scientific excellence.

HQ Significance:

The New York City headquarters was pivotal for Celmatix, providing access to a rich talent pool in technology, data science, and medicine, and facilitating connections with research institutions, partners, and the investment community vital for a growing biotech firm.

Values Reflected in HQ: The choice of a prominent New York City location in a modern facility underscored Celmatix's values of innovation, scientific rigor, and its ambition to be a leader at the intersection of technology and women's health.

Location:

While Celmatix was headquartered in the United States, its research, data-driven insights, and products, particularly in the realm of fertility and genomics, held global relevance and application. The company engaged in collaborations that extended its reach, and its technologies were designed with potential for international impact. Following the acquisition of its assets by Organon, Celmatix's innovations are now part of a company with an extensive global operational footprint, potentially broadening their availability worldwide.

Street Address:

222 Broadway, 19th Floor

City:

New York

State/Province:

NY

Country:

USA

Celmatix Therapeutics's Global Presence

Buying Intent Signals for Celmatix Therapeutics

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Celmatix Therapeutics

As of April 2025, Celmatix Therapeutics' leadership includes:

Dr. Piraye Yurttas Beim - Founder and Chief Executive Officer
Martin J. Angert - Chief Financial Officer (at time of acquisition)
Samir Kelekar, PhD - Chief Scientific Officer (at time of acquisition)

Investors of Celmatix Therapeutics

Celmatix Therapeutics has been backed by several prominent investors over the years, including:

Topspin Fund
Good Growth Capital
TDF Ventures
Rethink Impact
Female Founders Fund
Amgen Ventures
NIH Small Business Innovation Research (SBIR) Program
Slingshot Ventures

Executive New Hires/Exits in the Last 12 Months

Hire0
Exits0

In the 12 months preceding its asset acquisition by Organon in June 2022, the most significant 'executive news' for Celmatix centered on this major transition. This event fundamentally reshaped the company, leading to the wind-down of Celmatix as an independent operational entity. Consequently, its leadership structure was dissolved, with assets and technology integrated into Organon. Publicly announced individual executive hires or departures at Celmatix, distinct from the acquisition context, were not prominent during this specific period.

Technology (Tech Stack) used by Celmatix Therapeutics

Discover the tools Celmatix Therapeutics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Celmatix Therapeutics Email Formats and Examples

During its operational period, Celmatix likely used standard corporate email formats, commonly based on employee names such as [first].[last]@[companyname].com. Following the asset acquisition by Organon, active communication pertaining to former Celmatix technologies would now use Organon's email systems. The @celmatix.com domain is likely no longer actively used for new communications.

[first].[last]@celmatix.com

Format

jane.doe@celmatix.com

Example

85%

Success rate

News and media

Organon NewsJune 22, 2022

Organon Completes Acquisition of Celmatix Assets to Accelerate Innovation in Women's Health

Organon announced the completion of its acquisition of assets from Celmatix, Inc. This strategic move included Celmatix's preclinical-stage MAGE-A9 program for ovarian cancer, its innovative Fertilome® genetic test, and the Celmatix digital health platform, aiming to bolster Organon's portfolio in women's health....more

PRNewswireFebruary 5, 2019

Celmatix and CooperSurgical Announce New Partnership to Empower Women with Personalized Information About Their Reproductive Health

Celmatix and CooperSurgical unveiled a partnership to broaden access to MyFertilityCompass, a digital tool designed to offer women personalized, data-driven insights into their fertility. Powered by Celmatix's extensive research, the tool aimed to help women make proactive decisions regarding their reproductive health....more

MobiHealthNewsMarch 14, 2017

Celmatix launches Fertilome, the first comprehensive genetic screen for women's reproductive health

Celmatix announced the commercial launch of Fertilome®, a pioneering genetic test. It was designed to screen for dozens of genetic markers associated with female fertility, providing women and their healthcare providers with personalized information to better understand reproductive health risks and inform family planning strategies....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Celmatix Therapeutics, are just a search away.